Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research
Tirzepatide
We are hiring! Join our small and friendly team as a "Sales and Marketing Graduate". Apply today!
